23-09-2026 02:25
via
smh.com.au
New precision medicine venture gives Syngenis added firepower
Syngenis has joined Perron Institute and Gene S founders in a new precision-medicine venture that puts its integrated DNA and RNA biotech platform to work.
Read more »
Analyst news
The world economy is becoming wary of America
I want to control my car without crashing it. Here’s where design is going wrong
Oil platform 'a warning' as government considers new decommissioning rules
Mining sector keeps local shares from sinking into red
Fremantle Mayor beckons 40k-plus footy fans
Fuel price fears for Australia as global buffers dry up
Sacked city chief engages Martin Bennett to battle dismissal
Sacked city CEO Michelle Reynolds engages Martin Bennett to battle dismissal
Former WA premier Mark McGowan to join Southern Cross Media
The $16b Aussie tech firm in a slanging match over its China links
Wage-price spiral 'unlikely': RBA board member
Canberrans told to direct anger at Trump over nation's most costly fuel
ASX finishes flat as miners rise, oil stocks struggle; IDP plummets
'We've done nothing wrong': Firearms shop's gun laws plea after $800k loss
Desktop versie